Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis.
Postgrad Med J
; 100(1184): 366-372, 2024 May 18.
Article
en En
| MEDLINE
| ID: mdl-38200633
ABSTRACT
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Tuberculosis Resistente a Múltiples Medicamentos
/
Antituberculosos
Límite:
Humans
Idioma:
En
Revista:
Postgrad Med J
Año:
2024
Tipo del documento:
Article
País de afiliación:
China